Press release

DelleD signs with AgroCampus Ouest

Agrocampus Ouest and DelleD create the “AgroHealth Innovation” Chair

DelleD and the Agrocampus Ouest Foundation have joined forces to create an “AgroHealth” corporate chair. In order to elaborate an efficient agronomic engineering, under controlled conditions, aiming at optimizing and standardizing the architectural development of the cannabis plant. The “AgroHealth Innovation” chair is part of a context of evolution in agronomy practices where the lack …

Agrocampus Ouest and DelleD create the “AgroHealth Innovation” Chair Read More »

bpi financing preclinical trial in oncology for the LaFleur health project

DelleD – LaFleur obtains a public funding of 500k€ for the development of its cannabis-based drug for the treatment of cancers refractory to available therapies

At a time when France needs to support the strategic health sector, DelleD announces that it has obtained €500k in funding for its research project on cancer treatment. LAFLEUR: A LABORATORY FOR PLANT-BASED HEALTH INNOVATION Nearly 400,000 people are affected by cancer in France and the number of deaths is close to 160,000 people per …

DelleD – LaFleur obtains a public funding of 500k€ for the development of its cannabis-based drug for the treatment of cancers refractory to available therapies Read More »

Experimentation with cannabis for medical use

Call for tenders sprayers On 26 March, Health Minister Olivier Véran was in Clermont-Ferrand to announce the launch of the therapeutic cannabis experiment. Medical cannabis will be made available to patients for two years in two forms: oils administered orally and flowering tops (dried flowers) to be vaporised for inhalation. Following the announcement of the …

Experimentation with cannabis for medical use Read More »

Résultats expérimentation ANSM

Medical Cannabis: After the selection of foreign manufacturers, the place is now open to French companies.

The Agence Nationale de Sécurité du Médicament (ANSM) has published the results of the call for tenders for the supply and distribution of cannabis-based drugs for experimentation. RESULTS OF THE CALL FOR PROJECTS DelleD had applied and was one of the few French companies to have responded to this call for projects. The decree setting …

Medical Cannabis: After the selection of foreign manufacturers, the place is now open to French companies. Read More »

Therapeutic Cannabis to the rescue of heavy pathologies

A French pioneer in therapeutic cannabis-based medicines, LaFleur created by DelleD proposes the experimentation of a medical device of cannabis flower by vaporization in order to obtain a marketing authorization from the ANSM (National Agency for the Safety of Medicines and Health Products). DELLED PARTNERS WITH RYAH TO EXPERIMENT A CANNABIS FLOWER INHALER Article 1 …

Therapeutic Cannabis to the rescue of heavy pathologies Read More »

DelleD raises 3 million euros for therapeutic cannabis in France

Thanks to the private investor financing signed on July 31, 2020, DelleD can now accelerate its LaFleur project and develop its new oncology treatment based on cannabis assets. DELLED IS PURSUING ITS FLOWER RESEARCH PROGRAM AND SETTING UP IN ANGERS, FRANCE. Large-scale, long-term financing provides DelleD with the opportunity to expand its areas of expertise. …

DelleD raises 3 million euros for therapeutic cannabis in France Read More »

The first stocks of therapeutic cannabis delivered in France to develop a drug

In collaboration with DelleD SAS (“DelleD” or the “Company”), a French public laboratory received the first stocks of cannabis a few days ago. They will be used to carry out work on the processing for the elaboration of the first batches of cannabis intended for medical use and produced on the national territory. The government-mandated …

The first stocks of therapeutic cannabis delivered in France to develop a drug Read More »

error: Contenu protégé!

Venez découvrir notre nouveau site internet. Nous souhaitons que les professionnels de santé qui souhaitent se renseigner sur le cannabis médical aient accès aux dernières recherches scientifiques pour aider les patients en impasse thérapeutique.

Cet espace membre est exclusivement réservé aux professionnels de santé pour la formation du cannabis médical. Il permettra d'accompagner la création d'un programme intelligent du cannabis médical en France .
Si votre candidature est acceptée vous recevrez un mail de confirmation avec vos codes d’accès.